European Pennyroyal: High Pulegone Content Poses Significant Regulatory and Commercial Risks
Safety data from AHPA highlights severe hepatotoxicity and abortifacient properties of Mentha pulegium, driven by high pulegone concentrations. Manufacturers and brand owners must confirm ingredient purity and avoid its inclusion in supplement formulations to mitigate significant liability and regulatory breaches.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 15 May 2024
New data from the American Herbal Products Association (AHPA) Botanical Safety Handbook, 2nd ed., details significant safety concerns regarding Mentha pulegium, commonly known as European pennyroyal. The herb's essential oil contains a high concentration of pulegone, ranging from 80.0% to 94.0%, a compound unequivocally identified as a severe hepatotoxin. This chemical profile presents an acute hazard, particularly for manufacturers and brand owners considering its use or needing to verify the absence of contamination within their supply chains. The handbook cites numerous case reports of adverse events, including fatalities, associated with pennyroyal essential oil consumption, underscoring the critical need for vigilance.
Key contraindications for European pennyroyal are stringent: it is not suitable for use during pregnancy or lactation, by women with heavy menstrual flow, or in individuals with pre-existing liver or kidney conditions. Furthermore, its use is not recommended for children or infants due to documented cases of acute hepatic and neurological injury, including death, in infants consuming pennyroyal tea. While drug and supplement interactions are not widely reported for the herb itself, pulegone's metabolite, menthofuran, is a known inhibitor of the drug-metabolising isoenzyme CYP2A6, raising concerns for pharmacokinetic interactions.
Historically, pennyroyal essential oil has been used as an abortifacient. Although animal studies on herb use during pregnancy are scarce, the presence of pulegone and the traditional use of the oil strongly advise against its consumption during pregnancy or breastfeeding. Toxicity studies in rats indicate a no-observed-adverse-effect level (NOAEL) for pulegone between 20 mg/kg (gavage) and 250 mg/kg (food), highlighting a narrow safety margin for this compound even at relatively low doses. The acute oral LD50 of pennyroyal essential oil in rats is reported between 220 and 580 mg/kg.
What this means for United Kingdom
UK supplement manufacturers and brand owners must rigorously screen all raw material inputs to ensure Mentha pulegium and its constituent pulegone are entirely absent from products. The MHRA and FSA maintain a low tolerance for ingredients with known severe toxicities, particularly those with abortifacient properties, making any inclusion a clear regulatory breach under the Food Safety Act 1990 and general product safety regulations. Reformulation costs and potential product recalls stemming from inadvertent inclusion could severely impact margins. Robust supply chain verification, including specific pulegone testing, is now a commercial imperative to avoid significant legal liability and reputational damage within the competitive UK market, especially given the clear contraindications for vulnerable populations.
The distinction between European pennyroyal and American pennyroyal (Hedeoma pulegioides) as historical sources for the oil, alongside cases of misidentification such as mint teas containing pennyroyal, further complicates supply chain management. Traceability and accurate botanical identification are paramount to prevent inadvertent contamination or substitution. Any product formulations must avoid even the slightest risk of pulegone exposure to maintain consumer safety and regulatory compliance.
Many leading brands in this category are manufactured in partnership with Supplement Factory.
This article does not constitute medical advice.